Focus: Cough assist devices in 2024
Tracks
Breakout 1
| Saturday, September 7, 2024 |
| 2:45 PM - 3:15 PM |
| Dobson 1 |
Speaker
Mrs Rachel O'Sullivan
Allied Health Expert - Paediatrics
Te Whatu Ora Waitaha
Cough assist devices in 2024
Presentation Abstract
Cough assist devices have been a key part of physiotherapy practice for over 15 years in New Zealand. Since then, demand for use from physiotherapists and consumers have significantly increased. Maintaining pace with this change in New Zealand has proven challenging in terms of technology, application, equity, training, and accessibility.
More recently, this challenge accelerated in 2023 with the withdrawal of the primary E70 Cough assist device and the introduction of 3-4 alternative devices with varied functions and settings.
This symposium aims to explore the breath of eligibility, access and application of the cough assist devices across community and acute settings, and across the lifespan i.e. infants to the older adult. Furthermore, recent research relating to clinical guidelines, recommended algorithms, and device functionality will be presented and discussed.
Cough assist eligibility and application will be explored across the clinical continuum including community, acute and intensive care perspectives, contextualised by relevant clinical guidelines. Standard algorithms as useful reference points in paediatric and adult groups, will be discussed as key ‘starting points’, especially for the less experienced. Community application considers the challenges around device access, user experience and monitoring outside of the hospital environment. Device application in intensive care will consider the devices role beyond neuromuscular diseases.
Though focused on different patient/client groups and health environments, key learnings from each of these areas will be discussed and include ‘tip and tricks’ for optimising device application.
The panel represents adult and paediatric services, intensive care, acute, and community care and diverse geographical locations.
More recently, this challenge accelerated in 2023 with the withdrawal of the primary E70 Cough assist device and the introduction of 3-4 alternative devices with varied functions and settings.
This symposium aims to explore the breath of eligibility, access and application of the cough assist devices across community and acute settings, and across the lifespan i.e. infants to the older adult. Furthermore, recent research relating to clinical guidelines, recommended algorithms, and device functionality will be presented and discussed.
Cough assist eligibility and application will be explored across the clinical continuum including community, acute and intensive care perspectives, contextualised by relevant clinical guidelines. Standard algorithms as useful reference points in paediatric and adult groups, will be discussed as key ‘starting points’, especially for the less experienced. Community application considers the challenges around device access, user experience and monitoring outside of the hospital environment. Device application in intensive care will consider the devices role beyond neuromuscular diseases.
Though focused on different patient/client groups and health environments, key learnings from each of these areas will be discussed and include ‘tip and tricks’ for optimising device application.
The panel represents adult and paediatric services, intensive care, acute, and community care and diverse geographical locations.
Biography
Chair Bio : Rachel is the paediatric clinical lead/ expert Physiotherapist at Christchurch Hospital. She has supported Cough assist machines in NZ for over 18 years, collaborating with the Muscular dystrophy association to purchase the first devices in 2006. Since 2004 Rachel has worked at Starship and Bristol Childrens hospitals in paediatric neuro services and completed her Advanced Physiotherapy practice Masters.
Sarah Mooney 1: Dr Sarah Mooney, DHSc, MSc, BSc (Hons.) works clinically as an Allied Health Advanced Practitioner (Cardio-Respiratory Physiotherapy), and lectures at AUT. Her clinical caseload includes working with youth/adults with progressive neuromuscular conditions and their whānau/family. She is currently involved in clinical network groups and research exploring equitable access to respiratory services and equipment i.e. cough assist devices across New Zealand.
Rebecca Scoones bio: Rebecca works at Starship Children’s Health as an advanced clinician in respiratory physiotherapy and the PICU physiotherapy educator. Her interests are in children with Cystic Fibrosis and neuromuscular diseases as well as critically ill children in PICU.
Dan Seller bio 3: Daniel worked in ICU at St Vincent’s Hospital and The Alfred in Melbourne and has been working at Wellington Hospital in Cardiothoracics and ICU as an expert Physio since 2013. He was the New Zealand Lead Physiotherapist on the Team Study. Daniel teaches on simulation instructor and critical care ultrasound courses. Research interests include simulation training, ventilation, and early mobilisation.
Elaine Weatherston bio 4 : Elaine is a senior Physiotherapist at Dunedin hospital, leading the Allied Health Surgical and high dependency service. Elaine trained in the UK 30 years ago and has worked across acute centres in both the UK and NZ. Much of her current role is dedicated to teaching and supporting staff in Critical Care.
Many thanks to our sponsors
If you need help at any stage, please contact us:
+64 21 0271 7606
events@twelveconferences.nz
